Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.

Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.

Progressive multifocal leukoencephalopathy (PML), caused by replication of JC virus in oligodendrocytes of immunocompromised patients, is diagnosed by polymerase chain reaction-based demonstration of JC virus DNA. We investigated whether MRI might be used to assess disease activity. Diffusion-weight...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Mader, I, Herrlinger, U, Klose, U, Schmidt, F, Küker, W
Formato:	Journal article
Idioma:	English
Publicado em:	2003

Registos relacionados

Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.
Por: Küker, W, et al.
Publicado em: (2006)

Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease.
Por: Herrlinger, U, et al.
Publicado em: (2003)

Neonatal cerebral infarction diagnosed by diffusion-weighted MRI: pseudonormalization occurs early.
Por: Mader, I, et al.
Publicado em: (2002)

Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases.
Por: Küker, W, et al.
Publicado em: (2004)

Progressive multifocal leukoencephalopathy
Por: Rosca Elena Cecilia, et al.
Publicado em: (2008-12-01)

Progressive multifocal leukoencephalopathy
Por: Xiao⁃ling YAN
Publicado em: (2020-03-01)

Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Por: Küker, W, et al.
Publicado em: (2005)

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question
Por: Stefania Federica De Mercanti MD, PhD, et al.
Publicado em: (2020-07-01)

Progressive multifocal leukoencephalopathy: rheumatological aspects
Por: Boris Sergeevich Belov
Publicado em: (2015-09-01)

”Shrimp sign” in progressive multifocal leukoencephalopathy
Por: Ayush Agarwal, et al.
Publicado em: (2024-01-01)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Por: Nicolas Lambert, et al.
Publicado em: (2022-01-01)

AIDS-related progressive multifocal leukoencephalopathy
Por: Carolina de Oliveira Abrão, et al.
Publicado em: (2020-12-01)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
Por: J. Berciano
Publicado em: (2020-01-01)

Progressive Multifocal Leukoencephalopathy in an AIDS Patient
Por: Ming-Hsing Lee, et al.
Publicado em: (2007-01-01)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient
Por: Krisztina K. Johansen, et al.
Publicado em: (2013-09-01)

Multifocal Leukoencephalopathy
Por: J Gordon Millichap
Publicado em: (1994-05-01)

Progressive multifocal leukoencephalopathy lesion and brain parenchymal segmentation from MRI using serial deep convolutional neural networks
Por: Omar Al-Louzi, et al.
Publicado em: (2020-01-01)

Progressive multifocal leukoencephalopathy limited to the posterior fossa
Por: Rahmat, K., et al.
Publicado em: (2010)

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy
Por: Chandra Punch, et al.
Publicado em: (2016-01-01)

A rare case of progressive multifocal leukoencephalopathy
Por: Jayanthraj Gone, DO, et al.
Publicado em: (2024-10-01)

Milky way sign in progressive multifocal leukoencephalopathy
Por: Ayush Agarwal, et al.
Publicado em: (2022-01-01)

Progressive multifocal leukoencephalopathy in non-HIV patient
Por: Diego Rosseman Vieira, et al.

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Por: Martin Martinot, et al.
Publicado em: (2018-08-01)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Taiwanese Patient
Por: Yung-Yee Chang, et al.
Publicado em: (2007-01-01)

Progressive multifocal leukoencephalopathy treated with interleukin-7
Por: Karl B. Alstadhaug, et al.
Publicado em: (2020-10-01)

Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy
Por: Ajit Venniyoor
Publicado em: (2019-01-01)

Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging.
Por: Küker, W, et al.
Publicado em: (2004)

Diffusion-weighted MRI of spinal cord infarction--high resolution imaging and time course of diffusion abnormality.
Por: Küker, W, et al.
Publicado em: (2004)

Extensive progressive multifocal leukoencephalopathy as the first manifestation of AIDS
Por: Lénio Parreira do Couto, et al.
Publicado em: (2021-04-01)

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
Por: Peggy S. Eis, et al.
Publicado em: (2020-03-01)

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A KNOWN THYMOMA PATIENT
Por: Amun Iqbal, et al.
Publicado em: (2018-09-01)

Is There a (Host) Genetic Predisposition to Progressive Multifocal Leukoencephalopathy?
Por: Eli eHatchwell
Publicado em: (2015-05-01)

Progressive multifocal leukoencephalopathy in a lung transplant recipient
Por: Jason Sakizadeh, et al.
Publicado em: (2024-03-01)

Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia.
Por: Bruce, DR, et al.
Publicado em: (2014)

Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases
Por: Adcock, J, et al.
Publicado em: (1997)

Cerebellar Involvement in an Immunocompetent Patient Presenting with Progressive Multifocal Leukoencephalopathy
Por: Rafael Garcia-Carretero, et al.
Publicado em: (2017-01-01)

Mixed nontuberculous mycobacteria in an immunocompromised patient with progressive multifocal leukoencephalopathy
Por: Dr Christoffel Opperman, et al.
Publicado em: (2025-03-01)

Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient
Por: T. Nanda
Publicado em: (2016-01-01)

Progressive multifocal leukoencephalopathy cannot be due to liver cirrhosis alone
Por: Fulvio A. Scorza, et al.
Publicado em: (2024-02-01)

Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy
Por: Viviana Lo Buono, et al.
Publicado em: (2022-04-01)